These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32711805)

  • 1. Meta-analysis of the Safety and Efficacy of Bempedoic Acid.
    Khan MU; Khan MZ; Munir MB; Balla S; Khan SU
    Am J Cardiol; 2020 Sep; 131():130-132. PubMed ID: 32711805
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of bempedoic acid for prevention of cardiovascular events and diabetes: a systematic review and meta-analysis.
    Wang X; Zhang Y; Tan H; Wang P; Zha X; Chong W; Zhou L; Fang F
    Cardiovasc Diabetol; 2020 Aug; 19(1):128. PubMed ID: 32787939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Meta-Analysis of Cardiovascular Outcomes in Patients With Hypercholesterolemia Treated With Bempedoic Acid.
    Asbeutah AAA; Asbeutah SA; Abu-Assi MA
    Am J Cardiol; 2020 Oct; 132():166-168. PubMed ID: 32713651
    [No Abstract]   [Full Text] [Related]  

  • 4. Bempedoic acid for the treatment of hypercholesterolemia.
    Yang J
    Expert Rev Cardiovasc Ther; 2020 Jul; 18(7):373-380. PubMed ID: 32532162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bempedoic acid: A new player in lipid-lowering therapies.
    Cuevas A; Alonso R
    J Clin Lipidol; 2020; 14(5):615-616. PubMed ID: 32988798
    [No Abstract]   [Full Text] [Related]  

  • 6. Bempedoic Acid and the Prevention of Cardiovascular Disease.
    Keaney JF
    N Engl J Med; 2023 Apr; 388(15):1427-1430. PubMed ID: 36876758
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Di Minno A; Lupoli R; Calcaterra I; Poggio P; Forte F; Spadarella G; Ambrosino P; Iannuzzo G; Di Minno MND
    J Am Heart Assoc; 2020 Aug; 9(15):e016262. PubMed ID: 32689862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance.
    Nicholls S; Lincoff AM; Bays HE; Cho L; Grobbee DE; Kastelein JJ; Libby P; Moriarty PM; Plutzky J; Ray KK; Thompson PD; Sasiela W; Mason D; McCluskey J; Davey D; Wolski K; Nissen SE
    Am Heart J; 2021 May; 235():104-112. PubMed ID: 33470195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bempedoic Acid: First Approval.
    Markham A
    Drugs; 2020 May; 80(7):747-753. PubMed ID: 32314225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bempedoic Acid: A New Drug for an Old Problem.
    Nguyen D; Du N; Sulaica EM; Wanat MA
    Ann Pharmacother; 2021 Feb; 55(2):246-251. PubMed ID: 32674598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bempedoic Acid: A New Tool in the Battle Against Hyperlipidemia.
    Powell J; Piszczatoski C
    Clin Ther; 2021 Feb; 43(2):410-420. PubMed ID: 33384162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials.
    Bays HE; Banach M; Catapano AL; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Bloedon LT; Sasiela WJ; Ye Z; Ballantyne CM
    J Clin Lipidol; 2020; 14(5):649-659.e6. PubMed ID: 32980290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bempedoic acid as adjunct for traditional lipid-lowering therapy in patients with hyperlipidaemia.
    Schimmenti C; Sucato V; Manzone E; Cancellieri G; Mortillaro F; Novo G; Galassi AR; Venturella F
    Coron Artery Dis; 2021 Jun; 32(4):340-344. PubMed ID: 33229935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bempedoic acid on new onset or worsening diabetes: A meta-analysis.
    Masson W; Lobo M; Lavalle-Cobo A; Masson G; Molinero G
    Diabetes Res Clin Pract; 2020 Oct; 168():108369. PubMed ID: 32827596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis.
    Perera K; Kam N; Ademi Z; Liew D; Zomer E
    J Clin Lipidol; 2020; 14(6):772-783. PubMed ID: 32994152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Bempedoic Acid on atherogenic lipids and inflammation: A meta-analysis.
    Masson W; Lobo M; Lavalle-Cobo A; Molinero G
    Clin Investig Arterioscler; 2021; 33(3):117-126. PubMed ID: 33328138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of Bempedoic Acid - Clearer Now.
    Alexander JH
    N Engl J Med; 2023 Apr; 388(15):1425-1426. PubMed ID: 36876748
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and efficacy of ETC-1002 in hypercholesterolaemic patients: a meta-analysis of randomised controlled trials.
    Wang X; Luo S; Gan X; He C; Huang R
    Kardiol Pol; 2019; 77(2):207-216. PubMed ID: 30740643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A place for bempedoic acid: an effective therapeutic cooperation.
    Sbrana F; Dal Pino B; Bigazzi F; Sampietro T
    J Cardiovasc Med (Hagerstown); 2023 Jan; 24(1):75. PubMed ID: 36574303
    [No Abstract]   [Full Text] [Related]  

  • 20. Updated clinical evidence and place in therapy of bempedoic acid for hypercholesterolemia: ANMCO position paper.
    Colivicchi F; Di Fusco SA; Scicchitano P; Caldarola P; Murrone A; Valente S; Urbinati S; Roncon L; Amodeo V; Aspromonte N; Cipriani M; Domenicucci S; Francese GM; Imazio M; Scotto di Uccio F; Di Lenarda A; Gulizia MM; Gabrielli D
    J Cardiovasc Med (Hagerstown); 2021 Mar; 22(3):162-171. PubMed ID: 32842050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.